The annual national conference of the American Diabetes Association (ADA) this week served as a dual stage: a vibrant forum…
Read More
Remepy’s Hybridopa, a Pioneer in AI-Driven Hybrid Drugs, Demonstrates Significant Efficacy in Parkinson’s Phase IIa Trial
San Francisco, CA – May 2026 – Remepy, a burgeoning health technology startup at the vanguard of integrating pharmaceutical and…
Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
The intricate world of pharmaceutical research, particularly the demanding phases of clinical trials, stands at a pivotal juncture. Faced with…
Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
The landscape of clinical trials, a critical yet notoriously complex phase in drug development, is on the cusp of a…
Read More
Eli Lilly’s Retatrutide Achieves Unprecedented Weight Loss in TRIUMPH-1 Trial, Signaling New Era in Obesity Pharmacotherapy
NEW ORLEANS, LOUISIANA – At the 86th Scientific Sessions of the American Diabetes Association (ADA) held in New Orleans, Louisiana,…
Read More
SpliSense Advances Promising Cystic Fibrosis Therapy with Significant Funding and Phase IIb Trial Launch
The biotech firm SpliSense is making significant strides in the development of a novel therapy for cystic fibrosis, announcing a…
Read More
ADA Conference Concludes with Groundbreaking GLP-1 Trial Results Amidst Unprecedented Protests Over Science Policy
The annual scientific sessions of the American Diabetes Association (ADA) this week served as a pivotal platform for unveiling cutting-edge…
Read More
Parabilis Medicines Aims for $475 Million Nasdaq IPO to Fund Pivotal Desmoid Tumour Trial and Pipeline Expansion
Parabilis Medicines, a biopharmaceutical company forging innovative therapeutic pathways, is charting a course for public market debut with a proposed…
Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
A groundbreaking study, commissioned by eClinical Solutions and modeled by Hobson & Company, has unveiled compelling evidence of the transformative…
Read More
Ancient Chinese Exercise Baduanjin Proves as Effective as Brisk Walking for Lowering Blood Pressure in New Clinical Trial
A landmark randomized clinical trial published in JACC, the flagship journal of the American College of Cardiology, has revealed that…
Read MoreYOU MAY HAVE MISSED
